BridgeBio Pharma
@BridgeBioPharma
Hope Through Rigorous Science
Our mission is to discover, create, test and deliver transformative medicines to treat patients with genetic diseases. $BBIO
ID:1346634929099034624
https://www.bridgebio.com/ 06-01-2021 01:49:28
496 Tweets
1,1K Followers
165 Following
At the World Orphan Drug Congress Congress this week, Douglas Sproule M.D., M.Sc., CMO of our limb-girdle muscular dystrophy type 2I/R9 (LGMD2I/R9) program will be on a panel to discuss how to facilitate drug development in rare diseases. bit.ly/3W21pKi
This week at the World Orphan Drug Congress Congress, Sun-Gou Ji, Ph.D., BridgeBio’s VP of computational genomics will be presenting, about the benefits of leveraging genetic testing data to accelerate drug discovery for rare diseases. Learn more: bit.ly/3W21pKi
Our team will be at the International Congress of Myology Conference to present our novel bioassay measurement for alpha-dystroglycan, including Phase 2 and natural history data for our limb-girdle muscular dystrophy type 2I/R9 (LGMD2I / R9) program. bit.ly/43Z2CUx
For this year’s Light the Night, we gifted BridgeBio colleagues with red lightbulbs in hopes of spreading awareness around #AmyloidosisAwarenessMonth and the condition’s vast unmet need. Join us in the cause: bit.ly/3IbZrPR